Efficacy News and Research

RSS
Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Two specific gene variants speed progression of Parkinson's disease

Two specific gene variants speed progression of Parkinson's disease

Galectin Therapeutics commences Phase 1/2 trial of new treatment combination for advanced MM

Galectin Therapeutics commences Phase 1/2 trial of new treatment combination for advanced MM

AxioMed’s Freedom Cervical Disc receives CE Mark approval

AxioMed’s Freedom Cervical Disc receives CE Mark approval

Juventas begins enrollment in JVS-100 Phase IIa study for Rutherford Class 4 or 5 CLI

Juventas begins enrollment in JVS-100 Phase IIa study for Rutherford Class 4 or 5 CLI

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

Sinovac first quarter sales increase 30.3% to $6.0M

Sinovac first quarter sales increase 30.3% to $6.0M

CHDI, KineMed partner to investigate turnover rates of huntingtin protein

CHDI, KineMed partner to investigate turnover rates of huntingtin protein

SANUWAVE first quarter revenues decrease 5% to $238,540

SANUWAVE first quarter revenues decrease 5% to $238,540

Smoked cannabis may be an effective treatment for spasticity

Smoked cannabis may be an effective treatment for spasticity

BioAlliance Pharma commences Livatag phase III trial in hepatocellular carcinoma

BioAlliance Pharma commences Livatag phase III trial in hepatocellular carcinoma

Fibrocell submits azficel-T Phase II study protocol with FDA to treat restrictive burn scars

Fibrocell submits azficel-T Phase II study protocol with FDA to treat restrictive burn scars

Breast brachytherapy with strut-based applicator effective for early-stage breast cancer

Breast brachytherapy with strut-based applicator effective for early-stage breast cancer

Positive data from Piramal Healthcare’s BST-CarGel Phase III cartilage repair trial

Positive data from Piramal Healthcare’s BST-CarGel Phase III cartilage repair trial

Top-line data from S.L.A. Pharma’s Nalcol Phase 2 study on OIC

Top-line data from S.L.A. Pharma’s Nalcol Phase 2 study on OIC

New clinical trial to evaluate effectiveness of ABMT for PTSD

New clinical trial to evaluate effectiveness of ABMT for PTSD

Study reveals variability in physician intentions and recommendations on HPV vaccination

Study reveals variability in physician intentions and recommendations on HPV vaccination

DIBH can spare hearts and lungs of breast cancer patients from radiation

DIBH can spare hearts and lungs of breast cancer patients from radiation

Event addresses FDA's recent draft guidelines for development of biosimilar products

Event addresses FDA's recent draft guidelines for development of biosimilar products

Study describes new compounds that inhibit PRMT1 enzyme

Study describes new compounds that inhibit PRMT1 enzyme

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.